Woodline Partners LP

Position in LQDA — Liquidia Corp

CIK 1784547 San Francisco, CA

Position in LQDA

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$3,780,038

+$325,520 QoQ

Shares Held

100,160

0.0% QoQ

Ownership

0.113%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2022

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Woodline Partners LP holds $139,051,923 across 13 Drug Manufacturers - Specialty & Generic names. LQDA ranks #8 (2.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TEVA	Teva Pharmaceutical Industries Ltd	1,163,863	$35,055,553
2	SUPN	Supernus Pharmaceuticals, Inc.	448,996	$23,208,603
3	ALKS	Alkermes plc.	558,567	$19,750,929
4	PBH	Prestige Consumer Healthcare Inc.	273,943	$16,236,601
5	VTRS	Viatris Inc	1,167,948	$15,778,977
6	AMLX	Amylyx Pharmaceuticals, Inc.	845,800	$11,756,620
7	ETON	Eton Pharmaceuticals, Inc.	170,699	$4,212,851
8	LQDA	Liquidia Corp This page	100,160	$3,780,038

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,780,038	100,160	0.0%	Shares	Sole	2026-05-15
2025-12-31	$3,454,518	100,160	0.0%	Shares	Sole	2026-02-17
2025-09-30	$2,277,638	100,160	-75.0%	Shares	Sole	2025-11-14
2025-06-30	$4,985,993	400,160	+33.3%	Shares	Sole	2025-08-14
2025-03-31	$4,427,360	300,160	-28.8%	Shares	Sole	2025-05-15
2024-12-31	$4,958,992	421,683	+1.6%	Shares	Sole	2025-02-14
2024-09-30	$4,148,920	414,892	+55.8%	Shares	Sole	2024-11-14
2023-06-30	$2,090,243	266,273	-12.8%	Shares	Sole	2023-08-14
2023-03-31	$2,109,436	305,273	+173.0%	Shares	Sole	2023-05-15
2022-12-31	$712,261	111,815	-81.7%	Shares	Sole	2023-02-14
2022-09-30	$3,329,595	612,058	—	Shares	Sole	2022-11-14
No filing history on record for this holder in this stock.